The new reality of neuroblastoma treatment we’re working on uses targeted therapy, oral drugs, low side effects, and targets preventing relapse or treating relapse without punitive therapies.
We’ve built a national team of research and clinical collaborators to ensure kids across the US have access to these therapies, and created a consortium of 30+ children’s hospitals (the NMTRC) across the US to do so.
Our approach is two-fold:
Our research is in 30 hospitals, in over 20 states. We’re working to be in 40 institutions by the end of 2018.
Traveling is hard for families of kids with cancer. We’d like to be within a half day’s drive of the treating hospital.